Annual Net Income
-$7.44 M
+$11.40 M+60.51%
September 30, 2024
Summary
- As of February 12, 2025, SONN annual net profit is -$7.44 million, with the most recent change of +$11.40 million (+60.51%) on September 30, 2024.
- During the last 3 years, SONN annual net income has risen by +$17.55 million (+70.23%).
- SONN annual net income is now -52.68% below its all-time high of -$4.87 million, reached on September 30, 2019.
Performance
SONN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$3.13 M
+$377.00 K+10.75%
September 30, 2024
Summary
- As of February 12, 2025, SONN quarterly net profit is -$3.13 million, with the most recent change of +$377.00 thousand (+10.75%) on September 30, 2024.
- Over the past year, SONN quarterly net income has increased by +$377.00 thousand (+10.75%).
- SONN quarterly net income is now -956.21% below its all-time high of $365.40 thousand, reached on March 31, 2024.
Performance
SONN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$7.44 M
+$548.10 K+6.86%
September 30, 2024
Summary
- As of February 12, 2025, SONN TTM net profit is -$7.44 million, with the most recent change of +$548.10 thousand (+6.86%) on September 30, 2024.
- Over the past year, SONN TTM net income has increased by +$548.10 thousand (+6.86%).
- SONN TTM net income is now -287.04% below its all-time high of -$1.92 million, reached on March 31, 2020.
Performance
SONN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SONN Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.5% | +10.8% | +6.9% |
| 3 y3 years | +70.2% | +10.8% | +6.9% |
| 5 y5 years | -52.7% | +10.8% | +6.9% |
SONN Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.0% | -956.2% | +61.9% | at high | +75.0% |
| 5 y | 5-year | -52.7% | +75.0% | -956.2% | +73.4% | -287.0% | +76.2% |
| alltime | all time | -52.7% | +75.0% | -956.2% | +73.4% | -287.0% | +76.2% |
Sonnet BioTherapeutics Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$7.44 M(-60.5%) | -$3.13 M(-10.8%) | -$7.44 M(-6.9%) |
| Jun 2024 | - | -$3.51 M(-1059.4%) | -$7.99 M(-5.2%) |
| Mar 2024 | - | $365.40 K(-131.3%) | -$8.43 M(-41.7%) |
| Dec 2023 | - | -$1.17 M(-68.2%) | -$14.46 M(-23.2%) |
| Sep 2023 | -$18.83 M(-36.6%) | -$3.68 M(-6.8%) | -$18.83 M(-16.6%) |
| Jun 2023 | - | -$3.95 M(-30.4%) | -$22.59 M(-14.8%) |
| Mar 2023 | - | -$5.67 M(+2.3%) | -$26.52 M(-8.7%) |
| Dec 2022 | - | -$5.54 M(-25.5%) | -$29.06 M(-2.2%) |
| Sep 2022 | -$29.72 M | -$7.44 M(-5.6%) | -$29.72 M(+1.7%) |
| Jun 2022 | - | -$7.88 M(-4.0%) | -$29.24 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.21 M(+32.4%) | -$27.48 M(+8.6%) |
| Dec 2021 | - | -$6.20 M(-10.8%) | -$25.31 M(+1.3%) |
| Sep 2021 | -$24.98 M(+3.0%) | -$6.95 M(+13.7%) | -$24.98 M(-2.2%) |
| Jun 2021 | - | -$6.12 M(+1.3%) | -$25.55 M(-18.1%) |
| Mar 2021 | - | -$6.04 M(+2.8%) | -$31.22 M(+15.2%) |
| Dec 2020 | - | -$5.88 M(-21.8%) | -$27.10 M(+27.7%) |
| Sep 2020 | -$24.27 M(+398.1%) | -$7.52 M(-36.2%) | -$21.22 M(+54.9%) |
| Jun 2020 | - | -$11.78 M(+513.0%) | -$13.70 M(+613.0%) |
| Mar 2020 | - | -$1.92 M | -$1.92 M |
| Sep 2019 | -$4.87 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual net profit?
- What is the all time high annual net income for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual net income year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly net profit?
- What is the all time high quarterly net income for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly net income year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM net profit?
- What is the all time high TTM net income for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM net income year-on-year change?
What is Sonnet BioTherapeutics Holdings annual net profit?
The current annual net income of SONN is -$7.44 M
What is the all time high annual net income for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual net profit is -$4.87 M
What is Sonnet BioTherapeutics Holdings annual net income year-on-year change?
Over the past year, SONN annual net profit has changed by +$11.40 M (+60.51%)
What is Sonnet BioTherapeutics Holdings quarterly net profit?
The current quarterly net income of SONN is -$3.13 M
What is the all time high quarterly net income for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly net profit is $365.40 K
What is Sonnet BioTherapeutics Holdings quarterly net income year-on-year change?
Over the past year, SONN quarterly net profit has changed by +$377.00 K (+10.75%)
What is Sonnet BioTherapeutics Holdings TTM net profit?
The current TTM net income of SONN is -$7.44 M
What is the all time high TTM net income for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM net profit is -$1.92 M
What is Sonnet BioTherapeutics Holdings TTM net income year-on-year change?
Over the past year, SONN TTM net profit has changed by +$548.10 K (+6.86%)